Earth Science Tech (ETST) Net Equity Issued and Repurchased (2012 - 2024)
Earth Science Tech (ETST) posted Net Equity Issued and Repurchased of $330.0 for Q1 2024, down 99.7% on a QoQ basis from $110001.0 in Q2 2023, and down 99.87% year-over-year from $247700.0 in Q2 2023.
Earth Science Tech (ETST) Net Equity Issued and Repurchased (2012 - 2024) Analysis & Trends
Earth Science Tech's Net Equity Issued and Repurchased history runs 11 years deep, the most recent figure standing at $330.0 for Q1 2024.
- Quarterly Net Equity Issued and Repurchased fell 99.87% year-over-year to $330.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $110331.0 (down 58.79% YoY) and the FY2024 annual result came in at $110331.0, down 80.44% from the prior year.
- Net Equity Issued and Repurchased was $330.0 for Q1 2024 at Earth Science Tech, down from $110001.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $247700.0 in Q1 2023 and bottomed at $330.0 in Q1 2024.
- A 5-year average of $61231.4 and a median of $28175.0 in 2021 frame the typical range for Net Equity Issued and Repurchased.
- Annual changes were most pronounced in 2023 — Net Equity Issued and Repurchased surged 2377.0% — and 2024, when it slumped 99.87%.
- Earth Science Tech's Net Equity Issued and Repurchased stood at $19932.0 in 2020, then plunged by 49.83% to $10000.0 in 2021, then changed by 0.0% to $10000.0 in 2022, then surged by 1000.01% to $110001.0 in 2023, then tumbled by 99.7% to $330.0 in 2024.
- Business Quant data shows ETST's Net Equity Issued and Repurchased at $330.0 in Q1 2024, $110001.0 in Q2 2023, and $247700.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 500,000.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Earth Science Tech | 41.03 Mn | 38.90 Mn | 6.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 330.00 |
| Mar 31, 2024 | 330.00 |
| Jun 30, 2023 | 110,001.00 |
| Jun 30, 2023 | 110,001.00 |
| Mar 31, 2023 | 247,700.00 |
| Mar 31, 2023 | 247,700.00 |
| Mar 31, 2022 | 10,000.00 |
| Mar 31, 2022 | 10,000.00 |
| Dec 31, 2021 | 10,000.00 |
| Dec 31, 2021 | 10,000.00 |
| Jun 30, 2021 | 28,175.00 |
| Jun 30, 2021 | 28,175.00 |
| Sep 30, 2020 | 19,932.00 |
| Sep 30, 2020 | 19,932.00 |
| Jun 30, 2020 | 40,592.00 |
| Jun 30, 2020 | 40,592.00 |
| Mar 31, 2020 | 84,353.00 |
| Mar 31, 2020 | 84,353.00 |
| Dec 31, 2019 | 42,466.00 |
| Dec 31, 2019 | 42,466.00 |